{"id":"https://openalex.org/W2584462138","doi":"https://doi.org/10.1182/blood.v108.11.2595.2595","title":"GRN163L, a Potent and Specific Inhibitor of Telomerase: Integrated Pharmacokinetic, Pharmacodynamic, and Safety Data Guides Design of Practical Treatment Regimens for Targeting Inhibitory Levels in Patients.","display_name":"GRN163L, a Potent and Specific Inhibitor of Telomerase: Integrated Pharmacokinetic, Pharmacodynamic, and Safety Data Guides Design of Practical Treatment Regimens for Targeting Inhibitory Levels in Patients.","publication_year":2006,"publication_date":"2006-11-16","ids":{"openalex":"https://openalex.org/W2584462138","doi":"https://doi.org/10.1182/blood.v108.11.2595.2595","mag":"2584462138"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v108.11.2595.2595","doi":"https://doi.org/10.1182/blood.v108.11.2595.2595","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.2595.2595","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112905033","display_name":"Robert Tressler","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert J. Tressler","raw_affiliation_strings":["Oncology, Geron Corp, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Geron Corp, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111899982","display_name":"Allison C. Chin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Allison C. Chin","raw_affiliation_strings":["Oncology, Geron Corp, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Geron Corp, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040539933","display_name":"Eric Jay Feldman","orcid":"https://orcid.org/0009-0006-8191-7698","observed_orcids":["https://orcid.org/0009-0006-8191-7698"]},"institutions":[{"id":"https://openalex.org/I205783295","display_name":"Cornell University","ror":"https://ror.org/05bnh6r87","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295"]},{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric J. Feldman","raw_affiliation_strings":["Hematology/Oncology, Cornell Medical Ctr, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Cornell Medical Ctr, New York, NY, USA","institution_ids":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Kanti R. Rai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800560132","display_name":"Long Island Jewish Medical Center","ror":"https://ror.org/00c8v4891","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339","https://openalex.org/I2800560132"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kanti R. Rai","raw_affiliation_strings":["Hematology/Oncology, Long Island Jewish Medical Ctr, New Hyde Park, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology/Oncology, Long Island Jewish Medical Ctr, New Hyde Park, NY, USA","institution_ids":["https://openalex.org/I2800560132"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084958659","display_name":"Douglas J. Kornbrust","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Doug Kornbrust","raw_affiliation_strings":["Oncology, Geron Corp, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Geron Corp, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026652295","display_name":"Calvin B. Harley","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Calvin B. Harley","raw_affiliation_strings":["Oncology, Geron Corp, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Geron Corp, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012350798","display_name":"Melissa Kelly Behrs","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Melissa A. Kelly Behrs","raw_affiliation_strings":["Oncology, Geron Corp, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Geron Corp, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112240767","display_name":"Laurence Elias","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210114060","display_name":"Geron (United States)","ror":"https://ror.org/026vpvt76","country_code":"US","type":"company","lineage":["https://openalex.org/I4210114060"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Laurence Elias","raw_affiliation_strings":["Oncology, Geron Corp, Menlo Park, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, Geron Corp, Menlo Park, CA, USA","institution_ids":["https://openalex.org/I4210114060"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5012350798","https://openalex.org/A5026652295","https://openalex.org/A5084958659","https://openalex.org/A5111899982","https://openalex.org/A5112905033"],"corresponding_institution_ids":["https://openalex.org/I4210114060"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0963,"has_fulltext":false,"cited_by_count":3,"citation_normalized_percentile":{"value":0.48115789,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"108","issue":"11","first_page":"2595","last_page":"2595"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10937","display_name":"Telomeres, Telomerase, and Senescence","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10725","display_name":"RNA Interference and Gene Delivery","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10432","display_name":"DNA and Nucleic Acid Chemistry","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/grn163l","display_name":"GRN163L","score":0.996999979019165},{"id":"https://openalex.org/keywords/telomerase-inhibition","display_name":"telomerase inhibition","score":0.8349999785423279},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8640000224113464},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9350000023841858},{"id":"https://openalex.org/keywords/plasma-drug-concentration","display_name":"plasma drug concentration","score":0.44600000977516174},{"id":"https://openalex.org/keywords/cynomolgus-monkeys","display_name":"Macaca fascicularis","score":0.6890000104904175},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.46399998664855957},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.7689999938011169},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9700000286102295},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.37400001287460327},{"id":"https://openalex.org/keywords/coagulation-inhibition","display_name":"coagulation inhibition","score":0.5019999742507935},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.9710000157356262},{"id":"https://openalex.org/keywords/treatment-regimen-design","display_name":"treatment regimen design","score":0.3400000035762787}],"concepts":[{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.5813847780227661},{"id":"https://openalex.org/C94581717","wikidata":"https://www.wikidata.org/wiki/Q331839","display_name":"Telomerase","level":3,"score":0.5539773106575012},{"id":"https://openalex.org/C2777752497","wikidata":"https://www.wikidata.org/wiki/Q286779","display_name":"IC50","level":3,"score":0.4479309618473053},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3730412721633911},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3649218678474426},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.3564497232437134},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.352621853351593},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.17711108922958374},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v108.11.2595.2595","doi":"https://doi.org/10.1182/blood.v108.11.2595.2595","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v108.11.2595.2595","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.9476000070571899}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2247199183","https://openalex.org/W3009164101","https://openalex.org/W2023833929","https://openalex.org/W2524744840","https://openalex.org/W2481123790","https://openalex.org/W2125343208","https://openalex.org/W2343002411","https://openalex.org/W1968960900","https://openalex.org/W7100476677","https://openalex.org/W2360438127"],"abstract_inverted_index":{"Abstract":[0],"GRN163L":[1,41,91,114,172,189,343,411],"is":[2,63,348,412],"a":[3,207],"lipidated":[4],"thiophosphoramidate":[5],"oligonucleotide":[6],"that":[7,78,431],"binds":[8],"with":[9,313,361,381],"nanomolar":[10],"affinity":[11,55],"to":[12,30,52,67,88,161,177,193,223,230,327,368,387,418],"the":[13,53,68,145,215,253,265,352,362,369,397,413,429],"template":[14],"region":[15],"of":[16,59,80,97,144,228,249,342,373,385],"human":[17,47,81,125],"telomerase":[18,61,98,117,183,259,375,415,432],"RNA,":[19],"causing":[20],"direct":[21],"enzyme":[22],"inhibition.":[23,410],"Cellular":[24],"IC50":[25],"values":[26,355],"range":[27],"from":[28,217,356,424],"0.8":[29],"6.5":[31],"\u03bcg/mL":[32],"among":[33],"13":[34],"solid":[35],"and":[36,40,56,86,100,107,116,149,164,168,185,199,239,319,351],"hematologic":[37],"tumor":[38,43,48],"lines,":[39],"inhibits":[42],"growth":[44,106],"in":[45,93,123,173,175,264,317,345,349],"multiple":[46,213],"xenograft":[49],"studies.":[50],"Due":[51,367],"high":[54,153,398],"slow":[57],"off-rate":[58],"binding,":[60],"inhibition":[62,96,118,143,184],"long-lasting":[64],"following":[65],"exposure":[66,79],"drug":[69],"(Oncogene,":[70],"2005,":[71],"24,":[72],"5262).":[73],"Previously":[74],"reported":[75,157],"studies":[76,156],"demonstrated":[77,122],"myeloma":[82],"cell":[83,105],"lines":[84],"INA6":[85],"ARP":[87],"1":[89,254,282,386],"\u03bcM":[90,131,255],"resulted":[92],"\u2265":[94,281],"90%":[95],"activity":[99],"was":[101,190,221,310],"followed":[102],"by":[103],"reduced":[104],"survival":[108],"(Masood":[109],"et":[110,133],"al,":[111],"ASH":[112],"2005).":[113,136],"uptake":[115],"have":[119],"also":[120],"been":[121],"primary":[124],"CLL":[126,346],"cells":[127],"tested":[128],"at":[129,152,196,333,438],"2":[130,295],"(Lin":[132],"al.,":[134],"ASH,":[135],"Many":[137],"polyanionic":[138],"oligonucleotides":[139],"can":[140,435],"cause":[141],"reversible":[142],"intrinsic":[146],"coagulation":[147],"pathway":[148],"complement":[150,322],"activation":[151],"concentrations.":[154,395],"The":[155],"here":[158],"were":[159,204,330],"designed":[160],"determine":[162],"safe":[163],"well-tolerated":[165],"dose":[166,169,270],"schedules":[167],"ranges":[170],"for":[171,182,226],"primates":[174],"order":[176],"attain":[178],"plasma":[179,242,250,394],"levels":[180,203,243,251,434],"effective":[181],"anti-tumor":[186],"effects.":[187],"Methods:":[188],"administered":[191],"i.v.":[192],"cynomolgus":[194],"monkeys":[195],"varying":[197],"doses":[198,227,325],"infusion":[200,335],"durations.":[201,336],"Plasma":[202],"determined":[205],"using":[206],"validated":[208],"hybridization-ELISA":[209],"method.":[210],"Results:":[211],"In":[212],"studies,":[214],"T\u00bd\u03b1":[216,354,372],"two":[218],"compartment":[219],"modeling":[220],"2.9":[222],"5.3":[224],"hr":[225,389],"5":[229,268],"15":[231,290,328],"mg/kg.":[232],"Actual":[233],"(from":[234],"separate":[235],"but":[236],"representative":[237],"studies)":[238],"modeled":[240],"peak":[241,393],"(Cmax)":[244],"as":[245,247],"well":[246,331,439],"duration":[248,390],"above":[252],"(~4.8":[256],"\u03bcg/mL)":[257],"cellular":[258],"inhibitory":[260,376,433],"level":[261],"are":[262,359],"shown":[263],"table":[266],"below.":[267],"mg/kg":[269,305,329],"Observed":[271],"Cmax":[272,279,309],"From":[273],"Model":[274],"Inf":[275],"Dur":[276],"Mean":[277],"\u00b1SD":[278],"Level":[280],"\u03bcg/ml":[283,285],"hrs":[284,286],"Bolus":[287],"185\u00b18":[288],"153":[289],"0.5":[291],"200\u00b116":[292],"144":[293],"16":[294,298],"128\u00b13":[296],"122":[297],"6":[299,307,388],"63\u00b19":[300],"83":[301],"19":[302],"At":[303],"10":[304],"over":[306],"h,":[308],"90\u2013115":[311],"\u03bcg/mL,":[312],"<":[314],"2-fold":[315],"increases":[316],"APTT":[318],"no":[320],"significant":[321],"activation.":[323],"Repeated":[324],"up":[326],"tolerated":[332,440],"all":[334],"A":[337],"Phase":[338],"I/II":[339],"clinical":[340,420,426],"trial":[341],"infusions":[344,384,402],"patients":[347],"progress":[350],"observed":[353],"initial":[357],"cohorts":[358],"consistent":[360],"model":[363],"presented":[364],"here.":[365],"Conclusions:":[366],"relatively":[370],"long":[371],"GRN163L,":[374],"concentrations":[377],"should":[378],"be":[379,436],"attainable":[380],"clinically":[382],"practical":[383],"without":[391],"dose-limiting":[392],"Given":[396],"target":[399,409],"affinity,":[400],"such":[401],"repeated":[403],"intermittently":[404],"could":[405],"maintain":[406],"near":[407],"continual":[408],"first":[414],"targeted":[416],"agent":[417],"enter":[419],"trials.":[421],"Initial":[422],"results":[423],"these":[425],"trials":[427],"support":[428],"hypothesis":[430],"achieved":[437],"doses.":[441]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2017-02-10T00:00:00"}